New Quarter -- Same as the Old Quarter<br />By Rev Shark<br />RealMoney.com Contributor<br />4/1/2010 8:40 AM EDT<br /><br /> It is not the mountain we conquer, but ourselves.<br /> -- Edmund Hillary<br /><br />The first quarter of 2010 is now in the books, and it looked very much like most of 2009. The bulls weren't only victorious, they crushed the doubters and skeptics. The bulls pulled off yet another dramatic "V"-shaped bounce to new highs for the quarter.<br /><br />At the end of January, it looked like a long-awaited correction was upon us, but just when we were on the brink of gaining some downside momentum, the buyers stepped up and drove us straight back up to new highs. There have been almost no pullbacks during the seven-week rally off the early-February lows, and even the bulls have become frustrated with the lack of buying opportunities recently.<br /><br />Like many others, I was very surprised how easily the bulls drove this market back up. The sellers have been rendered inconsequential, and the worst thing you could do is try to fight this trend.<br /><br />The most confusing thing about this market is the lack of any strong emotions. While there doesn't seem to be any worry or fear, there hasn't been much euphoria or wild greed either. We seem to have enough skepticism to keep climbing a wall of worry but not enough worry to produce any real pullbacks.<br /><br />Riding an uptrend is usually much easier than it has been recently. The lack of volatility and consolidations and the perpetually overbought technical conditions make entries extremely difficult. The only way to put substantial capital to work is to chase stocks higher, and that simply isn't a viable methodology for many traders or investors.<br /><br />If there is a lesson to be learned or reinforced this past quarter, it's that trends tend to last longer and go further than seems reasonable. I doubt that even the most bullish of bulls expected this market to be so completely one-sided. The key to navigating this market has been to respect the trend and to not keep trying to anticipate when it will end. That isn't easy to do when we have such consistently positive action and are struggling to put capital to work, but the market never wants to make it too easy for us.<br /><br />We are kicking of the second quarter with another positive start. Economic reports from China and the eurozone were positive and all major overseas markets are in the green. Research In Motion's (RIMM) mediocre earnings report and a downgrade by Goldman is staying contained, and oil and commodities are leading us up in the early going.<br /><br />It is going to be very light trading today and we have the big employment report tomorrow when we are closed, so market players may hold off on making any major bets. Weekly unemployment numbers are very close to expectations, and we have ticked down just slightly on the news.<br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: XRTX +14.6%, CNAM +9.2%, SPIR +6.9% (light volume), RYAAY +6.4%, AEHR +6.3%, PEIX +6.3% (light volume), KNDI +4.9% (light volume), MU +4.6%, KMX +2.6%, GPN +1.6% (also upgraded to Outperform from Market Perform at Barrington), SPU +1.2%... M&A news: NGA +34.4% (AZZ signs agreement to acquire North American Galvanizing & Coatings for $7.50/share in cash), LIHR +28.3% (rejects A$9.2 bln offer from NEM - Bloomberg), SKIL +4.2% (announces agreement on terms of a revised recommended acquisition for cash by private investor group)... Select financial related names showing strength: PUK +3.1%, ING +2.4%, LYG +2.3%, BCS +2.1%, UBS +2.0%... Select metals/mining stocks trading higher: RTP +4.0%, BBL +3.0%, BHP +2.5%, VALE +2.2%, GOLD +2.0%, GDX +1.1%, GLD +0.4%... Select casino related names trading higher: MGM +2.1%, LVS +1.6%... Other news: BGP +33.7% (Borders announces $700 mln revolving credit facility and $90 mln term loan; BGP meets $42.5 mln obligation), RDEA +9.5% (announces positive top-line results from a Phase 2b Study of RDEA594 given as monotherapy in the treatment of hyperuricemia in gout patients), TRMA +7.3% (entered into the Second Waiver to Amended and Restated Credit Agreement), LNG +6.8% (Cheniere Energy confirms J.P. Morgan and Cheniere Energy partnership in LNG market), AMAG +3.1% (AMAG Pharma and Takeda Pharma announce collaboration for Feraheme in all therapeutic indications in select ex-US territories, including Europe), RMBS +1.3% (Advanced Micro renews patent license agreement with Rambus), TOT +0.9% (announces second oil discovery on deep offshore block 17/06 in Angola), SNY +0.9% (settles 3 lawsuits over Eloxatin - AP)... Analyst comments: AIXG +2.7% (initiated with a Buy at UBS), MICC +1.9% (upgraded to Overweight from Neutral at JP Morgan), BEN +1.8% (upgraded to Buy from Hold at Citigroup), AB +1.2% (upgraded to Buy from Hold at Citigroup), BIDU +0.7% (Baidu target raised to $752 from $604 at Deutsche Bank),<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: NCOC -23.2% GRRF -21.6% , EFJI -8.5% , RINO -7.3% , RIMM -5.5% (also downgraded to Sell from Neutral at Goldman), MOS -1.8%... Other news: IDI -21.4% (intends to file a Form 12b-25 with the SEC on April 1, 2010, to delay the filing of its Annual Report on Form 10-K for the year ended December 31, 2009), IRE -5.6% (still checking for anything specific), CIM -5.1% (announced an 85 mln share common stock offering), NRP -4.7% (announces pricing of public offering of common units at $25.17/share), QKLS -4.7% (postpones earnings release date for fourth quarter and full year 2009 financial results), BRE -3.2% (announces offering of five mln shares of common stock)... Analyst comments: BLK -2.6% (downgraded to Hold from Buy at Deutsche Bank and downgraded to Sell from Buy at Citigroup).